The company, the operator of language tutoring platform 51Talk, has raised $58m from backers including strategic partner Duowan Entertainment.

The corporate-backed pharmaceutical company has postponed an initial public offering for the second time, a week after it set the terms.

The diagnostics technology developer, backed by Allscripts, Celgene and Blackberry, has filed for an initial public offering provisionally sized at up to $92m.

The gene editing company raised $108m in its IPO, floating at the top of its range, while Regeneron and Novartis provided $55m through concurrent private placements.

Viamet, which has raised about $170m from backers including Novartis, Eli Lilly and Astellas, is set to raise up to $91m, after withdrawing its last IPO filing in 2014.

The gene editing company expects to raise up to $90m, while Novartis and Regeneron are set to invest $55m through private placements.

HNA Tourism and Legend-backed holiday home rental portal Zhubaijia has listed on China's Neeq exchange.

The app-based home cleaning service has floated on the National Equities Exchange and Quotations market after raising four rounds of funding from investors including Tencent and Shanda.

The dyslipidemia treatment developer has filed for a $60m initial public offering that will allow Pfizer, from which it licensed its lead candidate, to exit.

Eye disease therapy developer GenSight Biologics, which had raised almost $78m from investors including Novartis, has withdrawn an IPO expected to raise up to $70m.